The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...

People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes ...

President Trump's reciprocal tariffs have led to unprecedented trillions in foreign investments into US manufacturing.

Scientists have discovered why males get dental disease more frequently and with greater severity than females, pinpointing ...

Eggs are rich in proteins, healthy fats, minerals, and vitamins. A gastroenterologist explained some of their benefits when consumed regularly for a period of two weeks. He also suggested an equally ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) sells medicines for eye conditions, immune disorders, cancer, cardiovascular issues, infections, and rare diseases.

A University of Kentucky professor said the research has the potential to someday prevent millions of cases of Alzheimer’s in ...

Following the federal government's changes to COVID-19 vaccine eligibility and recommendations in 2025, many people are ...

Beyond relieving pressure on existing NHS services, home testing could offer patients greater choice, more convenience, ...

In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, discusses 3-year data from the GALE study on geographic atrophy treatment with pegcetacoplan.

A key protein, LRG1, was identified as the early cause of diabetic eye damage, and blocking it may stop the disease before ...